Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of bcl-2

被引:170
作者
Blutt, SE
McDonnell, TJ
Polek, TC
Weigel, NL [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA
关键词
D O I
10.1210/en.141.1.10
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While the role of vitamin D in bone and mineral metabolism has been investigated extensively, the role of the vitamin D receptor in other tissues is less well understood. 1,25-dihydroxyvitamin D, (calcitriol) can act as a differentiating agent in normal tissues and can inhibit the growth of many cancer cell lines including LNCaP prostate cancer cells. We have shown previously that calcitriol causes LNCaP cell accumulation in the G(0)/G(1) phase of the cell cycle. In this study, we demonstrate that calcitriol also induces apoptosis of LNCaP cells. The calcitriol-induced apoptosis is accompanied by a down-regulation of Bcl-2 and Bcl-X-L proteins, both of which protect cells from undergoing apoptosis. Other proteins important in apoptotic control, Bar, Mcl-1, and Bcl-X-s, are unaffected by calcitriol treatment. We find that overexpression of Bcl-2 blocks calcitriol-induced apoptosis and reduces, but does not eliminate, calcitriol-induced growth inhibition. We conclude that both regulation of cell cycle and the apoptotic pathway are involved in calcitriol action in prostate cancer cells.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 54 条
  • [1] Auwerx J, 1999, CELL, V97, P161
  • [2] BCHAM A, 1997, ONCOGENE, V15, P2767
  • [3] 1,25-dihydroxyvitamin D-3, transforming growth factor beta 1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes
    Benassi, L
    Ottani, D
    Fantini, F
    Marconi, A
    Chiodino, C
    Giannetti, A
    Pincelli, C
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 276 - 282
  • [4] BENEZRA JM, 1994, AM J PATHOL, V145, P1036
  • [5] 1,25-Dihydroxyvitamin D-3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G(1)
    Blutt, SE
    Allegretto, EA
    Pike, JW
    Weigel, NL
    [J]. ENDOCRINOLOGY, 1997, 138 (04) : 1491 - 1497
  • [6] SUPPRESSION OF TUMORIGENICITY OF HUMAN PROSTATE CARCINOMA-CELLS BY REPLACING A MUTATED RB GENE
    BOOKSTEIN, R
    SHEW, JY
    CHEN, PL
    SCULLY, P
    LEE, WH
    [J]. SCIENCE, 1990, 247 (4943) : 712 - 715
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] P53 ONCOGENE MUTATIONS IN 3 HUMAN PROSTATE-CANCER CELL-LINES
    CARROLL, AG
    VOELLER, HJ
    SUGARS, L
    GELMANN, EP
    [J]. PROSTATE, 1993, 23 (02) : 123 - 134
  • [9] EPIDEMIOLOGIC EVIDENCE REGARDING PREDISPOSING FACTORS TO PROSTATE-CANCER
    CARTER, BS
    CARTER, HB
    ISAACS, JT
    [J]. PROSTATE, 1990, 16 (03) : 187 - 197
  • [10] CARTER HB, 1990, PROSTATE, V16, P39